Formoterol fumarate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
577 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 23 | 51 | 115 | 46 | 47 | 274 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 24 | 47 | 88 | 61 | 45 | 257 |
| Obstructive lung diseases | D008173 | — | — | 12 | 29 | 60 | 41 | 24 | 163 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 2 | 25 | 49 | 33 | 22 | 128 |
| Emphysema | D004646 | EFO_0000464 | J43 | — | — | 4 | 5 | — | 9 |
| Bronchitis | D001991 | — | J40 | — | — | 3 | 5 | — | 8 |
| Disease progression | D018450 | — | — | — | — | 1 | 3 | 3 | 7 |
| Cough-variant asthma | D000096823 | — | J45.991 | 1 | 1 | — | 4 | 1 | 6 |
| Pulmonary emphysema | D011656 | — | J43 | — | — | 2 | 4 | — | 6 |
| Chronic bronchitis | D029481 | — | J42 | — | — | 2 | 4 | — | 6 |
Show 21 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Respiratory aspiration | D053120 | EFO_1001839 | — | 3 | 3 | 1 | — | 1 | 7 |
| Covid-19 | D000086382 | — | U07.1 | — | 2 | 2 | — | 1 | 4 |
| Allergic bronchopulmonary aspergillosis | D001229 | EFO_0007140 | B44.81 | — | 4 | 4 | — | — | 4 |
| Infections | D007239 | EFO_0000544 | — | — | 1 | 1 | — | 1 | 3 |
| Communicable diseases | D003141 | — | — | — | 1 | 1 | — | 1 | 3 |
| Respiratory insufficiency | D012131 | — | J96.9 | — | — | 2 | — | — | 2 |
| Aspergillosis | D001228 | EFO_0007157 | B44 | — | 2 | 2 | — | — | 2 |
| Pulmonary aspergillosis | D055732 | EFO_1001834 | — | — | 2 | 2 | — | — | 2 |
| Dyspnea | D004417 | — | R06.0 | — | — | 1 | — | 1 | 2 |
| Urticaria | D014581 | EFO_0005531 | L50 | — | — | 1 | — | — | 1 |
Show 5 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | — | 4 | — | — | — | 4 |
| Bronchiolitis obliterans | D001989 | EFO_0007183 | J44.81 | — | 3 | — | — | — | 3 |
| Bronchiolitis | D001988 | — | — | — | 3 | — | — | — | 3 |
| Medication adherence | D055118 | EFO_0006344 | — | 2 | 2 | — | — | — | 2 |
| Interstitial lung diseases | D017563 | EFO_0004244 | J84.9 | — | 1 | — | — | — | 1 |
| Cryptogenic organizing pneumonia | D018549 | EFO_1001300 | J84.116 | — | 1 | — | — | — | 1 |
| Organizing pneumonia | D000092124 | — | — | — | 1 | — | — | — | 1 |
| Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | 1 | — | — | — | 1 |
| Acute lung injury | D055371 | EFO_0004610 | — | — | 1 | — | — | — | 1 |
| Lung injury | D055370 | — | S27.30 | — | 1 | — | — | — | 1 |
Show 11 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 9 | — | — | — | 2 | 11 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
| Precancerous conditions | D011230 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Allergic rhinitis | D065631 | — | J30.9 | — | — | — | — | 3 | 3 |
| Rhinitis | D012220 | EFO_0008521 | J31 | — | — | — | — | 2 | 2 |
| Personal satisfaction | D010549 | — | — | — | — | — | — | 1 | 1 |
| Patient satisfaction | D017060 | — | — | — | — | — | — | 1 | 1 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
| Hypoglycemia | D007003 | — | E16.2 | — | — | — | — | 1 | 1 |
| Bronchial hyperreactivity | D016535 | — | — | — | — | — | — | 1 | 1 |
| Hypertrophy | D006984 | EFO_0002460 | — | — | — | — | — | 1 | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 1 | 1 |
Show 11 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
11,324 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use